Commonwealth Equity Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Commonwealth Equity Services, LLC

$66 Billion
Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 18,981 shares of REGN stock, worth $13.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

18,981

Previous 20,152 5.81%

Holding current value

$13.6 Million

Previous $21.2 Million 5.79%

% of portfolio

0.03%

Previous 0.03%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$1024.09 - $1201.76 $1.2 Million - $1.41 Million	-1,171 Reduced 5.81%	18,981 $20 Million
Q2 2024 Jul 31, 2024	BUY	$883.2 - $1071.19 $688,896 - $835,528	780 Added 4.03%	20,152 $21.2 Million
Q1 2024 Apr 29, 2024	BUY	$902.69 - $993.35 $474,814 - $522,502	526 Added 2.79%	19,372 $18.6 Million
Q4 2023 Feb 06, 2024	BUY	$775.18 - $881.7 $393,791 - $447,903	508 Added 2.77%	18,846 $16.6 Million
Q3 2023 Oct 23, 2023	SELL	$692.45 - $844.37 $44,316 - $54,039	-64 Reduced 0.35%	18,338 $15.1 Million
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $1.58 Million - $1.87 Million	-2,254 Reduced 10.91%	18,402 $13.2 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $124,529 - $151,335	183 Added 0.89%	20,656 $17 Million
Q4 2022 Feb 07, 2023	BUY	$705.89 - $766.39 $2.54 Million - $2.76 Million	3,600 Added 21.34%	20,473 $14.8 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $470,655 - $593,942	-820 Reduced 4.63%	16,873 $11.6 Million
Q2 2022 Jul 19, 2022	BUY	$548.35 - $738.84 $850,490 - $1.15 Million	1,551 Added 9.61%	17,693 $10.5 Million
Q1 2022 May 04, 2022	SELL	$595.12 - $698.43 $3.59 Million - $4.21 Million	-6,025 Reduced 27.18%	16,142 $11.3 Million
Q4 2021 Jan 31, 2022	SELL	$543.48 - $670.97 $1.01 Million - $1.25 Million	-1,867 Reduced 7.77%	22,167 $14 Million
Q3 2021 Oct 29, 2021	BUY	$574.03 - $680.96 $4.38 Million - $5.19 Million	7,628 Added 46.5%	24,034 $14.5 Million
Q2 2021 Aug 11, 2021	BUY	$472.8 - $558.54 $1.04 Million - $1.23 Million	2,200 Added 15.49%	16,406 $9.16 Million
Q1 2021 May 04, 2021	BUY	$446.73 - $548.2 $1.07 Million - $1.31 Million	2,390 Added 20.23%	14,206 $6.72 Million
Q4 2020 Feb 11, 2021	SELL	$478.3 - $607.98 $187,493 - $238,328	-392 Reduced 3.21%	11,816 $5.71 Million
Q3 2020 Nov 05, 2020	SELL	$544.75 - $658.21 $324,671 - $392,293	-596 Reduced 4.65%	12,208 $6.83 Million
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $947,667 - $1.24 Million	1,921 Added 17.65%	12,804 $7.99 Million
Q1 2020 May 11, 2020	BUY	$336.18 - $494.43 $475,022 - $698,629	1,413 Added 14.92%	10,883 $5.31 Million
Q4 2019 Feb 05, 2020	SELL	$274.13 - $376.51 $144,466 - $198,420	-527 Reduced 5.27%	9,470 $3.56 Million
Q3 2019 Oct 30, 2019	BUY	$273.46 - $318.39 $113,759 - $132,450	416 Added 4.34%	9,997 $2.77 Million
Q2 2019 Jul 19, 2019	BUY	$299.6 - $414.82 $217,509 - $301,159	726 Added 8.2%	9,581 $3 Million
Q1 2019 May 13, 2019	SELL	$372.08 - $439.57 $29,766 - $35,165	-80 Reduced 0.9%	8,855 $3.64 Million
Q4 2018 Feb 11, 2019	BUY	$335.82 - $403.04 $334,812 - $401,830	997 Added 12.56%	8,935 $3.34 Million
Q3 2018 Nov 06, 2018	BUY	$351.14 - $408.51 $520,038 - $605,003	1,481 Added 22.94%	7,938 $3.21 Million
Q2 2018 Jul 31, 2018	BUY	$284.6 - $344.99 $219,426 - $265,987	771 Added 13.56%	6,457 $2.23 Million
Q1 2018 May 14, 2018	BUY	$315.82 - $393.78 $134,855 - $168,144	427 Added 8.12%	5,686 $1.96 Million
Q4 2017 Feb 12, 2018	BUY	$358.63 - $469.95 $1.89 Million - $2.47 Million	5,259	5,259 $1.98 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Account

Commonwealth Equity Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History